Scherer Jonas, Whybra-Trümpler Catharina, Mildenberger Eva
Neonatologie, Universitätsmedizin Zentrum für Kinder- und Jugendmedizin, Johannes Gutenberg-Universität Mainz, Mainz.
Z Geburtshilfe Neonatol. 2020 Dec;224(6):367-373. doi: 10.1055/a-1164-7174. Epub 2020 Jun 5.
Therapeutic hypothermia (TH) improves the outcome in newborns with hypoxic-ischemic encephalopathy (HIE) and should be used in case of perinatal asphyxia and signs of moderate/severe HIE.
MATERIAL/METHODS: Frequency of HIE and the application of TH were extracted from the neonatal survey, a registry that collects data from all German hospitals, and from the hypothermia registry, established in 2010. The latter was also used to analyze short-term outcomes of the newborns.
Between 2010 and 2017, 106 of Germany's 213 perinatal centers joined the registry. Response rates varied between 22 and 60%. The registry recorded 164 (IQR 115-224) TH cases per year in newborns with HIE. In the neonatal survey, 517 (382-664) TH and 543 (432-581) HIE cases were reported. Since 2014 there have been more cases of TH than HIE. After TH, 10.4% (8-13%) of the newborns died, 81% (78-82%) of the newborns were discharged home, 3.6% (3-5%) to a rehabilitation facility, and 5.4% (5-7%) transferred to another clinic. 89% (87-89%) were on complete oral feedings.
After the introduction of TH in the clinical routine, the number of treated newborns increased continuously. Currently, the number of TH is higher than the number of children with HIE, which is difficult to explain, as the presence of a moderate or severe HIE is a mandatory requirement for TH. The data from the hypothermia registry showed no significant changes in mortality or neurological outcome over time.
治疗性低温(TH)可改善新生儿缺氧缺血性脑病(HIE)的预后,在围产期窒息及中度/重度HIE体征的情况下应使用。
材料/方法:从新生儿调查(一个收集德国所有医院数据的登记处)以及2010年建立的低温登记处提取HIE的发生率和TH的应用情况。后者还用于分析新生儿的短期预后。
2010年至2017年期间,德国213个围产期中心中的106个加入了该登记处。响应率在22%至60%之间。该登记处记录了每年164例(四分位间距115 - 224)HIE新生儿接受TH治疗的病例。在新生儿调查中,报告了517例(382 - 664)TH治疗病例和543例(432 - 581)HIE病例。自2014年以来,接受TH治疗的病例比HIE病例更多。接受TH治疗后,10.4%(8% - 13%)的新生儿死亡,81%(78% - 82%)的新生儿出院回家,3.6%(3% - 5%)转至康复机构,5.4%(5% - 7%)转至另一诊所。89%(87% - 89%)的新生儿完全经口喂养。
在临床常规中引入TH治疗后,接受治疗的新生儿数量持续增加。目前,TH治疗的数量高于HIE患儿的数量,这难以解释,因为中度或重度HIE的存在是TH治疗的必要条件。低温登记处的数据显示,随着时间推移,死亡率或神经学预后无显著变化。